Introduction
Advances in antiretroviral therapy (ART) have resulted in greatly reduced mortality among people living with HIV [1, 2] , such that life expectancy for HIV-positive individuals with access to treatment now approaches that of the general population [3] . International [4] [5] [6] and UK [7] guidelines recommend that patients are involved in decision-making about HIV care and treatment. For this to be achieved, patients require adequate knowledge of their HIV-related health and treatment goals, and are dependent on health care professionals providing and discussing the relevant information.
Reviewing laboratory markers such as CD4 counts and HIV viral load (VL) in conjunction with a patient is now common practice amongst HIV health care providers. Previous studies have suggested that providing health-related knowledge to people with HIV infection may improve adherence and treatment outcomes, as well as benefitting the patientÀhealth care provider relationship [8] [9] [10] . Furthermore, as increasing evidence shows that a suppressed HIV VL greatly reduces the risk of onward transmission of HIV to sexual partners [11] [12] [13] [14] [15] [16] [17] , people with HIV infection may use their VL results to make decisions on condomless sex. Therefore, in this context, it is critical that individuals have correct self-knowledge of their latest VL result.
Little is known about the accuracy of individuals' knowledge of their own HIV biomarker status, or whether socioeconomic and other factors impact on such knowledge. In particular, there have been no studies assessing the accuracy of self-report of VL status among people living with HIV in the UK. Despite access to free HIV care in the UK via the National Health Service, recent results from the Antiretrovirals, Sexual Transmission Risk and Attitudes (ASTRA) study indicated that socioeconomic disadvantage was associated with a substantially increased probability of virological nonsuppression and virological rebound among people on treatment for HIV infection in the UK [18] . In this study, we used data from ASTRA to investigate the ability of individuals on ART to correctly report their HIV VL level and CD4 count level, by comparing self-report with the clinic-recorded value. We also assessed the association of demographic, socioeconomic, HIV-related and health-related factors with inaccurate reporting of HIV VL level.
Methods

Study design and procedures
ASTRA is a cross-sectional questionnaire study that recruited people with diagnosed HIV infection from eight HIV out-patient clinics in the UK between February 2011 and December 2012 [19] . The time period allocated for recruitment in each clinic was of sufficient duration that infrequent clinic attendees would be included in those invited to participate. Exclusion criteria were as follows: age < 18 years; unable to understand the study questionnaire (available in English or French) because of language or cognitive difficulties; too ill or distressed to complete the questionnaire. Participants self-completed a confidential paper questionnaire that included items on demographics (gender/sexual orientation; age; ethnicity), socioeconomic factors (UK birth/English fluency; education; employment; housing; financial hardship; supportive network assessed by a modified version of the Duke Functional Social Support questionnaire [18, 20] Participants who reported that they had ever started ART were asked to report the value of their VL from the last time they received their test results, with three options: "50 copies/mL or less ('undetectable' or 'suppressed)"; "more than 50 copies/mL ('detectable' or 'raised')"; or "don't know". All participants were asked to report their last CD4 count result, with five options; "less than 200"; "200-350"; "351-500"; "more than 500"; or "don't know/can't remember". For all participants, the study recruiter documented, from clinic records, the latest VL and CD4 count laboratory results that were available to the participant at the time the questionnaire was issued. Therefore, information on VL and CD4 levels was available both from the participant self-report and from the clinic record.
Agreement between self-report and clinic record for VL and CD4 was assessed only among participants who reported currently taking ART. Accurate self-report was defined as agreement between participant self-report and clinic record that the latest VL was either ≤ 50 copies/mL or > 50 copies/mL. Inaccurate selfreport was defined as either disagreement between selfreport and clinic record on the level of VL, or a response of "don't know" to the question on VL level. Participants who had no clinic-recorded VL, whose clinic-recorded VL was dated after the questionnaire issue date, or who gave no response to the question on VL level were excluded from the analysis. Similarly, accuracy of reporting CD4 count was defined as agreement between participant self-report and clinic record that the latest CD4 count was > 350 or ≤ 350 cells/lL. Inaccurate self-report was defined as indicating a different CD4 count category from that of the clinicrecorded CD4 count, or a response of "don't know". Analysis of factors associated with inaccurate selfreport was carried out for VL only, as it was posited that, among those on ART, VL may be monitored more regularly than CD4 count. In addition, knowledge of VL level is of particular importance in relation to decision-making around sexual behaviour.
Statistical analysis
Agreement between participant self-report and clinic record for VL level and CD4 level was assessed among participants on ART. In order to examine the associations of demographic, socioeconomic, HIV-related and healthrelated factors with inaccurate self-report of VL level, modified Poisson regression models with robust standard errors were used to produce unadjusted and adjusted prevalence ratios (PRs) with 95% confidence intervals (CIs) [23] . In multivariable analyses, each factor was considered in a separate model and adjusted only for: gender/ sexual orientation [men who have sex with men (MSM), heterosexual men and women], age group (< 30, 30-39, 40-49, 50-59, ≥ 60 years, and missing), ethnicity (white, black African, black other, and other/ missing) and time since first starting ART group (≤ 6 months, 6 months to 1 year, 1-2 years, 2-5 years, 5-10 years, > 10 years, and missing). Results were similar when cases with missing values for age and time since starting ART were excluded from analysis. Further adjustment for (or stratification by) clinical centre had little effect on associations; associations unadjusted for clinical centre are presented. In a separate sensitivity analysis, participants who gave no response to the question on self-reported VL level were included in the "disagreement" category (inaccurate self-report) rather than being excluded.
Results
In total, 3258 patients completed a study questionnaire, of 5112 invited to participate (response rate of 64%). Of 3202 participants with ART information, 2771 (86.5%) were on ART, 366 were ART na€ ıve, and 65 had previously taken ART but were not on ART at the time of the questionnaire. Of 2771 participants on ART, 1891 (68.2%) were MSM, 547 (19.7%) were women and 333 (12.0%) were heterosexual men ( Table 1 
Agreement between self-reported and clinic-recorded VL
Among the 2771 participants on ART, the clinic-recorded VL was not documented for 18 participants, and was dated after the questionnaire issue for a further 11 participants. In addition, 64 individuals did not provide a response to the question on self-reported VL. Among the remaining 2678 participants, 2334 (87.2%) had clinicrecorded VL ≤ 50 copies/mL. Self-reported VL was as follows: 2137 (79.8%) participants reported VL ≤ 50 copies/ mL, 232 (8.7%) reported VL > 50 copies/mL, and 309 (11.5%) responded "don't know" (Table 2a ). In terms of agreement, of the 2334 participants with a clinic VL ≤ 50 copies/mL, a high proportion (88.3%; n = 2061) correctly self-reported undetectable VL; 49 (2.1%) incorrectly self-reported that their VL was detectable, while 224 (9.6%) did not know their latest VL. Of the 344 participants with clinic-recorded VL > 50 copies/mL, 183 (53.2%) correctly self-reported detectable VL; however, Agreement between self-reported and clinic-recorded CD4 count
Among 2771 participants on ART, the clinic-recorded CD4 count was not documented for 19 participants, and was dated after questionnaire issue for a further 15. In addition, 70 individuals did not respond to the self- Disagreement between clinic-recorded and self-reported undetectable VL status, or "don't know" response for self-report. ‡ Analysis excludes 93 of 2771 individuals on ART. Exclusions were: missing clinic-recorded viral load (n = 18); clinic-recorded viral load dated after questionnaire issue (n = 11); missing self-reported viral load (n = 64). § Unadjusted and adjusted prevalence ratios and 95% confidence intervals using modified Poisson regression. For adjusted analyses, each factor is included in a separate model and adjusted for "gender/sexual orientation", "age group", "ethnicity" and "time since started ART group". Denominators are equivalent for unadjusted and adjusted analyses, as in multivariable models, "age group" and "time since started ART" were fitted using a "missing" category (n = 51 and n = 80 missing values, respectively). P values were obtained using the score statistic. 
Demographic and socioeconomic factors and accuracy of self-reported VL
In unadjusted analysis, demographic characteristics associated with inaccurate self-report of VL were: gender/sexual orientation (women and heterosexual men were more likely to have inaccurate self-report compared with MSM), younger age (those < 30 years old were more likely to have inaccurate self-report compared with all other age groups) and nonwhite ethnicity (Table 1 ). There were striking associations with socioeconomic factors: non-UK birth/low English fluency, nonuniversity education, nonemployment (other than retirement), being in rented or unstable housing, and greater financial hardship were strongly associated with a higher prevalence of inaccurate self-report. Low supportive network was also associated with inaccurate self-report. In analyses adjusted for gender/sexual orientation, age group, ethnicity, and time since started ART group, most associations were attenuated, but indicators of socioeconomic disadvantage remained strongly associated with inaccurate self-report (Table 1) . For example, those who did not have enough money for basic needs had more than twice the prevalence of incorrectly self-reporting their VL status compared with those who always had enough money. Similarly, compared with those who owned their own home, those in unstable accommodation had twice the prevalence of incorrectly self-reporting their VL status. Those who were non-UK born and reported poor English fluency had more than three times the prevalence of incorrectly self-reporting their VL status compared with those born in the UK (which may in part reflect difficulties with comprehension of the question on the latest VL level). Gender/sexual orientation and ethnicity were independently associated with inaccurate self-report in the model including both factors together with age group and time since started ART group, but associations were attenuated.
HIV-related factors and accuracy of self-reported VL
In unadjusted analyses, not having a stable partner and nondisclosure of HIV status were associated with inaccurate self-report of VL. A shorter time since starting ART was strongly associated with inaccurate self-report, with a particularly high prevalence among those who had very recently started ART (when VL level is likely to be changing rapidly). Self-reported nonadherence to ART was also strongly associated with inaccurate self-report: for example, the prevalence was twice as high among those who missed three or more doses in the past 2 weeks compared with those who reported no missed doses. The prevalence of inaccurate self-report was also somewhat higher for those whose latest VL results were > 6 months ago compared with more recent. These associations were similar after adjustment for gender/sexual orientation, ethnicity, age group and time since started ART group (Table 1) .
Mental health and accuracy of self-reported VL
Depression symptoms and anxiety symptoms were strongly associated with inaccurate self-report in unadjusted and adjusted analyses. For example, in the adjusted analysis, the prevalence of inaccurate self-report was increased approximately twofold for those with current depressive symptoms. Treatment for depression was also associated with inaccurate self-report in the adjusted analysis (Table 1) .
Sensitivity analysis
When participants who did not provide an answer to the question on self-reported VL (n = 64) were included in the "disagreement" category, the proportion of participants with inaccurate self-report of VL was 18.2% (498 of 2742). When 70 participants with missing self-report of CD4 count level were classified as "disagreement", the proportion of participants with inaccurate self-report of CD4 count level was 24.9% (682 of 2737). Associations of factors with inaccurate self-report of VL were very similar to those found in the main analysis (results not shown).
Discussion
We report on levels of agreement between self-report and clinic-recorded laboratory values of VL and CD4 count in people treated for HIV infection in the UK. A minority (16%) of HIV-positive individuals on ART did not correctly self-report whether their VL was undetectable. A quarter (25.0%) of HIV-positive individuals on ART did not correctly self-report their CD4 count within broad categories. Heterosexual male and female gender/sexual orientation, non-white ethnicity, lower socioeconomic status, poor English fluency, low supportive network, not having a stable partner, nondisclosure of HIV status, having recently started ART, ART nonadherence and poorer mental health were associated with inaccurate self-report of VL. To our knowledge, this is the first European study to assess agreement between self-reported and clinicrecorded HIV VL and CD4 count. Our findings are comparable to those of several studies assessing accuracy of reporting of HIV biomarkers in people with HIV in the USA, most of which found overall moderate levels of agreement between self-report and medical record, and which found evidence that younger age, lower education, lower health literacy and socioeconomic disadvantage were associated with inaccurate self-report of VL and CD4 count [24] [25] [26] [27] [28] . Our results suggest that, even in a UK setting with free access to health care and treatment, socioeconomic disadvantage is strongly linked to lack of knowledge of HIV-related markers.
HIV is a life-long, chronic condition and proficient knowledge of HIV health markers among people with HIV infection supports self-management, which can impact on engagement and retention in care [29] . Reasons for lack of knowledge of personal VL level in those with disadvantaged socioeconomic circumstances are likely to be complex and multifaceted. Lower levels of knowledge could in part be a consequence of health ranking as a lower priority in the context of immediate pressures. For example, financial, housing, employment or family difficulties may result in prioritization of these issues above personal health. This may impact on attendance at, or engagement with, health services. For patients who are non-UK born with lower English fluency, this language barrier alone can result in anxiety and stress at clinic appointments, and make clinic interactions difficult and thus harder to engage with. Our study suggests that those with a lower level of education are also less likely to have accurate knowledge of their VL status, which may be linked to health literacy, and may also make HIV appointments stressful or confusing, and potentially reduce motivation to attend. Depression and other mental health problems may adversely impact on motivation and prioritization of HIV-related health.
The results could also be interpreted as showing that health providers are less successful in actively engaging HIV-positive people who have more complex needs in their own health care. Possible strategies to improve such engagement may include having clearer explanations after diagnosis about the importance of CD4 count and VL and what they mean for care, and having printed resources in languages other than English with involvement of peer advocates who speak the mother languages. In addition, greater training and resources on these issues for health professionals themselves may be needed. It is also important to note that lack of knowledge of personal VL level may be related to the approach taken by a doctor in discussing results with a patient. Specific values of laboratory test results may not always be given to all patients, a strategy that could be viewed as appropriate in some circumstances. In some cases, doctors may only communicate results if there is something to be concerned about. For example "undetectable viral load", or an exact value of the CD4 count, might not be directly explained by a doctor if they think their patient would prefer a more general summary of HIV health status. A doctor might choose instead perhaps to emphasize adherence and say that generally everything is okay. Insights into this level of patientÀdoctor communication are beyond the scope of this study.
Defining engagement in care is complex, and requires more than a single measure of appointment attendance [30] [31] [32] [33] . One previous study from the USA used multiple markers including knowledge of personal CD4 count and antiretroviral treatment, medication adherence, and appointment attendance, to form a composite measure of engagement [30] . In our study, knowledge of personal VL level was strongly associated with ART adherence. Previous studies have found that greater engagement with care was associated with higher prevalence of viral suppression [30, 33] . Further investigation of self-knowledge of VL as a predictor of engagement in care could help identify those patients at risk of becoming disengaged.
Strong evidence now demonstrates that viral suppression as a result of ART substantially reduces infectiousness of HIV-positive people to sexual partners [11] [12] [13] [14] [15] [16] [17] . Further evidence indicates that some MSM may use viral suppression in decision-making about condomless sex [34] [35] [36] [37] [38] . In the ASTRA study, there was evidence that knowledge of suppressed VL impacted on condom use among MSM, although the effect was modest at the time of the study, and was not apparent for heterosexual men and women [38] . The accuracy of reporting an undetectable VL by HIV-positive individuals on ART is directly relevant for their HIV-negative sexual partners, if the HIV-positive partner's VL influences decision-making around condom use. The high level of accuracy of a selfreported undetectable VL found in this UK study is encouraging, as this implies that decisions to have condomless sex on this basis will generally be well informed. Of all participants who self-reported undetectable VL, < 4% did not have a VL ≤ 50 copies/mL. Furthermore, among this subset who incorrectly reported an undetectable VL, the majority had a clinic-recorded value < 1000 copies/mL, making HIV transmission very unlikely. However, it is important to recognize that the prevalence of VL suppression (both overall and among those with self-reported undetectable VL) and awareness of personal VL level may be overestimated in our study as it was conducted among HIV-positive individuals attending clinic and who agreed to participation, suggesting a degree of engagement in care. As ART use expands and knowledge about the protective effect of ART on HIV transmission is publicized and disseminated, further attention should be paid to ensure that all HIV-positive people on ART are able to correctly self-report whether their latest HIV VL is undetectable. The importance of ART adherence and regular VL testing for those with HIV-negative sexual partners should also be emphasized in this context.
A strength of the ASTRA study is that it included a large, unselected sample of people with diagnosed HIV infection in the UK, in contrast to similar studies on this topic from the USA that have mainly been conducted among low-income or hard-to-reach populations and had smaller sample sizes. [24] [25] [26] [27] [28] . Our study has some limitations. Knowledge of HIV biomarkers may have been overestimated if such knowledge was poorer among study nonresponders, those not eligible for the study because of language difficulties, those without the opportunity to be invited because of very infrequent clinic attendance, or the small number of participants who had missing data on ART status. Although study personnel were asked to record the latest clinic values of VL and CD4 that had been communicated to the participant, accuracy of selfreport may be underestimated if cases of disagreement were attributable to participants recalling VL test results from a different date from the clinic-recorded test.
Our results demonstrate high accuracy of a selfreport of undetectable VL among people receiving ART in the UK. Overall accuracy of self-report varied according to demographic, socioeconomic, HIV and health-related factors. Indicators of socioeconomic disadvantage, nondisclosure of HIV status, poorer ART adherence, and poorer mental health were strongly linked to inaccurate knowledge of VL. We identify a need for a stronger clinical focus on a specific group of patients, characterized by adverse socioeconomic circumstances, to improve their knowledge and experience of HIV care, as well as those with limited English who should be routinely offered access to interpreter services. Accurate knowledge of VL is important at both an individual and a public health level. Further consideration should be given to including it as part of a composite tool to measure engagement in care, together with a clinic plan for subsequent interventions to support people who are not engaged.
